Increased Nonvertebral Fracture Risk After Roux-en-Y Bypass

This article originally appeared here.
Share this content:
Increased Nonvertebral Fracture Risk After Roux-en-Y Bypass
Increased Nonvertebral Fracture Risk After Roux-en-Y Bypass

TUESDAY, March 7, 2017 (HealthDay News) -- Roux-en-Y gastric bypass (RYGB) is associated with increased nonvertebral fracture risk compared with adjustable gastric banding (AGB), according to a study published online March 2 in the Journal of Bone and Mineral Research.

Elaine W. Yu, M.D., from Massachusetts General Hospital in Boston, and colleagues compared fracture risk in obese adults after RYGB and AGB procedures using claims data from a U.S. commercial health plan. They examined rates of nonvertebral fractures within a propensity-score matched cohort of 15,032 morbidly obese adults who underwent RYGB or AGB surgery from 2005 to 2013.

During a mean follow-up of 2.3±1.9 years there were 281 nonvertebral fractures. The researchers found that compared with AGB patients, RYGB patients had increased risk of nonvertebral fracture (hazard ratio, 1.43). RYGB patients had increased risk of fracture at the hip and wrist (hazard ratios, 1.54 and 1.45, respectively) in fracture site-specific analyses. The risk of nonvertebral fracture associated with RYGB manifested more than two years after surgery and increased in subsequent years; the highest risk was seen in the fifth year after surgery (hazard ratio, 3.91).

"Fracture risk should be considered in risk:benefit discussions of bariatric surgery, particularly among patients with high baseline risk of osteoporosis who are deciding between RYGB and AGB procedures," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »